Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas

Clinical Endocrinology

Volumn 72, Issue 5, 2010, Pages 648-653

  Cho, Hwa Young ^a   Cho, Sun Wook ^a   Kim, Sang Wan ^a,b   Shin, Chan Soo ^a   Park, Kyong Soo ^a   Kim, Seong Yeon ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; LUTEINIZING HORMONE; TESTOSTERONE; THYROTROPIN; THYROXINE;

ACTH SECRETING ADENOMA; ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GAMMA KNIFE RADIOSURGERY; HEADACHE; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYPERPROLACTINEMIA; HYPOGONADISM; HYPOPHYSIS ADENOMA; HYPOPHYSIS APOPLEXY; HYPOTHYROIDISM; IMMUNOREACTIVITY; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PREVALENCE; PRIORITY JOURNAL; REVIEW; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TUMOR RECURRENCE; TUMOR VOLUME; VISUAL DISORDER;

ADENOMA; ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 77950266824     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03673.x     Document Type: Review

References (9)

1. Black, P.M., Hsu, D.W., Klibanski, A. et al. (1987) Hormone production in clinically nonfunctioning pituitary adenomas. Journal of Neurosurgery, 66, 244 250.
2. Horvath, E., Kovacs, K., Killinger, D.W. et al. (1980) Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. American Journal of Pathology, 98, 617 638.
3. Ebersold, M.J., Quast, L.M., Laws Jr., E.R. et al. (1986) Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. Journal of Neurosurgery, 64, 713 719.
4. Greenman, Y. Melmed, S. (1996) Diagnosis and management of nonfunctioning pituitary tumours. Annual Review of Medicine, 47, 95 106.
5. Bradley, K.J., Wass, J.A. Turner, H.E. (2003) Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clinical Endocrinology (Oxf), 58, 59 64.
6. Scheithauer, B.W., Jaap, A.J., Horvath, E. et al. (2000) Clinically silent corticotroph tumours of the pituitary gland. Neurosurgery, 47, 723 729. Discussion 729-730.
7. Webb, K.M., Laurent, J.J., Okonkwo, D.O. et al. (2003) Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study. Neurosurgery, 53, 1076 1084. Discussion 1084-1075.
8. Baldeweg, S.E., Pollock, J.R., Powell, M. et al. (2005) A spectrum of behaviour in silent corticotroph pituitary adenomas. British Journal of Neurosurgery, 19, 38 42.
9. Bates, A.S., Farrell, W.E., Bicknell, E.J. et al. (1997) Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. Journal of Clinical Endocrinology and Metabolism, 82, 818 824.